Connecticut 2020 Regular Session

Connecticut House Bill HB05250

Introduced
2/20/20  
Refer
2/20/20  
Refer
2/20/20  
Report Pass
3/10/20  

Caption

An Act Prohibiting Requirements For Prescribing Clinically Inappropriate Quantities Of Outpatient Psychotropic Drugs.

Impact

The enactment of HB 05250 has the potential to significantly influence state health laws, particularly in the management and prescription of psychotropic medications. It seeks to remove barriers imposed by insurance policies that could lead to non-ideal outcomes for patients who may have specific therapeutic needs that require personalized treatment plans. Furthermore, it promotes the importance of physician discretion when prescribing medications that can substantially affect mental health and well-being.

Summary

House Bill 05250 aims to prohibit health insurance policies from mandating that healthcare providers prescribe outpatient psychotropic drugs in quantities deemed clinically inappropriate. This legislative act is intended to enhance prescribing autonomy by allowing the healthcare professionals to make decisions based on their clinical judgment, ensuring that treatment plans are tailored and appropriate for each individual patient. The bill mandates that from January 1, 2021, such stipulations shall not be a condition of coverage for outpatient prescription drugs provided under state law or funded by state resources.

Contention

The bill has sparked discussions regarding the balance between necessary regulation and the freedom of healthcare providers to make individualized treatment decisions. While supporters advocate for the bill on the grounds of improving patient care and physician autonomy, critics might be concerned about the implications of such autonomy on the standardization and management of psychotropic medications. The conversation around this bill indicates broader themes in health policy, including the roles of insurers and the state in healthcare decisions, as well as the ongoing debates about mental health treatment accessibility and appropriateness.

Companion Bills

No companion bills found.

Previously Filed As

CT SB00182

An Act Prohibiting Certain Health Carriers From Requiring Step Therapy For Prescription Drugs Used To Treat A Mental Or Behavioral Health Condition Or A Chronic, Disabling Or Life-threatening Condition.

CT SB00008

An Act Concerning Drug Affordability.

CT SB00133

An Act Concerning Regulation Of Prescription Drugs And Related Professions.

CT SB00400

An Act Concerning The Insurance Department's Technical Corrections And Other Revisions To The Insurance Statutes.

CT HB05198

An Act Concerning Telehealth.

CT SB00210

An Act Concerning A State-operated Reinsurance Program, Health Care Cost Growth And Site Of Service Billing Requirements.

CT SB00401

An Act Concerning The Availability Of Telehealth Providers In Determining Network Adequacy And Extending The Telehealth Provisions Adopted During The Covid-19 Pandemic.

CT SB00001

An Act Concerning The Health And Safety Of Connecticut Residents.

CT HB05503

An Act Concerning Insurance Market Conduct And Insurance Licensing, The Insurance Department's Technical Corrections And Other Revisions To The Insurance Statutes And Captive Insurance.

CT HB05488

An Act Concerning Various Revisions To The Public Health Statutes.

Similar Bills

No similar bills found.